Scinai Immunotherapeutics Regains Nasdaq Compliance

Scinai Immunotherapeutics Ltd (NASDAQ: SCNI) has regained compliance with Nasdaq Listing Rule 5550(a)(2) after maintaining a closing bid price at or above $1.00 for 19 consecutive business days. Nasdaq has confirmed that the minimum bid price issue is now resolved.